Perkins Capital Management Inc. decreased its position in CryoPort Inc (NASDAQ:CYRX) by 37.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 126,250 shares of the consumer goods maker’s stock after selling 76,740 shares during the quarter. Perkins Capital Management Inc.’s holdings in CryoPort were worth $1,084,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Zurcher Kantonalbank Zurich Cantonalbank bought a new position in CryoPort in the third quarter worth $118,000. Bank of Montreal Can bought a new position in CryoPort in the fourth quarter worth $142,000. Northern Trust Corp raised its holdings in CryoPort by 105.0% in the second quarter. Northern Trust Corp now owns 22,179 shares of the consumer goods maker’s stock worth $109,000 after purchasing an additional 11,358 shares in the last quarter. Wolverine Trading LLC bought a new position in CryoPort in the third quarter worth $230,000. Finally, Granite Investment Partners LLC bought a new position in CryoPort in the third quarter worth $535,000. Institutional investors and hedge funds own 18.16% of the company’s stock.

Shares of CryoPort Inc (NASDAQ CYRX) traded up $0.29 during trading hours on Friday, hitting $8.91. The stock had a trading volume of 200,313 shares, compared to its average volume of 92,916. CryoPort Inc has a 1 year low of $1.96 and a 1 year high of $10.40. The company has a market capitalization of $218.38, a P/E ratio of -17.52 and a beta of 0.99.

CryoPort (NASDAQ:CYRX) last issued its quarterly earnings results on Wednesday, November 1st. The consumer goods maker reported ($0.08) earnings per share for the quarter, meeting the consensus estimate of ($0.08). CryoPort had a negative return on equity of 46.99% and a negative net margin of 91.28%. sell-side analysts anticipate that CryoPort Inc will post -0.32 earnings per share for the current fiscal year.

A number of equities analysts have issued reports on the company. Janney Montgomery Scott increased their price objective on CryoPort from $10.00 to $12.00 and gave the stock a “buy” rating in a report on Tuesday, October 3rd. Roth Capital assumed coverage on CryoPort in a report on Thursday, November 30th. They issued a “buy” rating and a $12.50 price objective for the company. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $33.50.

WARNING: “Perkins Capital Management Inc. Decreases Holdings in CryoPort Inc (CYRX)” was originally published by Daily Political and is the property of of Daily Political. If you are reading this story on another domain, it was copied illegally and republished in violation of US & international trademark & copyright laws. The legal version of this story can be read at https://www.dailypolitical.com/2018/01/26/perkins-capital-management-inc-decreases-holdings-in-cryoport-inc-cyrx.html.

CryoPort Company Profile

Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.

Want to see what other hedge funds are holding CYRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CryoPort Inc (NASDAQ:CYRX).

Institutional Ownership by Quarter for CryoPort (NASDAQ:CYRX)

Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.